Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RTX vs MRNA✓SelectedUSD · MRNARTX vs MRNA performance historyLatest closeAs of-1.86%11/16
Stock and ETF performance explorer

RTX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+11.6%
MRNA return
+330.7%
Excess return
-319.1%
Maximum drawdown
-20.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.9%-3.6%+1.8%-1.9%
7D-0.7%-20.0%+19.3%-0.9%
30D+0.5%-1.3%+1.8%+0.5%
3M-12.6%+240.0%-252.6%-10.7%
All+11.6%+330.7%-319.1%+8.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling